2010
DOI: 10.1016/j.imlet.2010.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
45
0
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 68 publications
(46 citation statements)
references
References 38 publications
(42 reference statements)
0
45
0
1
Order By: Relevance
“…Underlined metabolites were measured by the LC-MS/MS method described amide (NAm) and nicotinic acid (NA) [6]. Most catabolites are biologically active and involved in the pathogenesis of many disease processes [7][8][9][10][11][12]. Furthermore, the interrelationship between metabolic pathways is of profound pharmacological and physiological importance as changes in one pathway might have secondary effects on the others [1].…”
Section: Introductionmentioning
confidence: 99%
“…Underlined metabolites were measured by the LC-MS/MS method described amide (NAm) and nicotinic acid (NA) [6]. Most catabolites are biologically active and involved in the pathogenesis of many disease processes [7][8][9][10][11][12]. Furthermore, the interrelationship between metabolic pathways is of profound pharmacological and physiological importance as changes in one pathway might have secondary effects on the others [1].…”
Section: Introductionmentioning
confidence: 99%
“…50 IDO activation is suggested to ameliorate GvHD severity and mortality. [56][57][58] High expression of IDO in intestinal mucosal mononuclear cells and low expression in endothelial cells were associated with favorable outcome in intestinal GvHD. 59 In our study, we could find higher IDO expression levels after allogeneic BMT in both HIP and LIP animals.…”
Section: Discussionmentioning
confidence: 99%
“…Two possible mechanisms of apoptosis are proposed: 1) depletion of tryptophan (de la Maza and Peterson, 1988;Ozaki et al, 1988;Lee et al, 2002;Platten et al, 2012) and 2) production of toxic tryptophan metabolites in the kynurenine pathway, such as kynurenines and 3-hydroxyanthranilic (3-HAA) (Morita et al, 2001;Fallarino et al, 2003;Mailankot et al, 2009;Lee et al, 2010;Mailankot and Nagaraj, 2010;Song et al, 2011;Hou et al, 2014). In this study, we demonstrated that the addition of either the IDO inhibitor 1-MT or L-tryptophan could decrease IFN-γ-induced reduction of cell viability ( Figure 5A) and apoptosis ( Figure 5B-E).…”
Section: Discussionmentioning
confidence: 99%